February 1, 2023

Merck wins patent battle over hepatitis c drugs

Pin It

By Scott Graham, From The Recorder Gilead Sciences Inc.’s once impermeable defense of its hepatitis C medications has been cracked. Merck & Co. Inc. won a jury verdict of validity Tuesday on two patents covering the key ingredient in the blockbuster drugs Sovaldi and Harvoni. Gilead isn’t contesting infringement, and the trial proceeded to a […]